⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for nilotinib 200mg

Every month we try and update this database with for nilotinib 200mg cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Nilotinib Plus Dabrafenib/Trametinib in Metastatic MelanomaNCT04903119
Metastatic Mela...
BRAF Gene Mutat...
Nilotinib 100mg
Nilotinib 200mg
Nilotinib 300mg
Nilotinib 400mg
Dabrafenib
Trametinib
18 Years - University of Kentucky
Nilotinib Plus Dabrafenib/Trametinib in Metastatic MelanomaNCT04903119
Metastatic Mela...
BRAF Gene Mutat...
Nilotinib 100mg
Nilotinib 200mg
Nilotinib 300mg
Nilotinib 400mg
Dabrafenib
Trametinib
18 Years - University of Kentucky
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: